Advanta VXT and Flixene Graft Registry
Part of Heart & circulation clinical trials.
This registry follows people who have already received an Advanta VXT or Flixene graft to repair or replace a peripheral artery. It collects information from medical records to see how the grafts perform over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery to replace or repair a peripheral artery using an Advanta VXT or Flixene graft.
- You were at least 18 years old when you had that surgery.
- You have medical records that go back at least 3 years after the surgery.
- At the time of the graft surgery, you did not have an active infection in the area where the graft was placed.
- You are willing and able to sign a consent form to take part in this registry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information on people who have or will have a leg artery procedure to open blocked blood vessels. It helps doctors learn more about how well these procedures work and how to improve care.
This trial tests a new synthetic bypass graft for people with advanced leg artery blockages. It may help avoid using your own veins for surgery and could improve blood flow to your legs.
This study collects information about people who had a procedure to improve blood flow in certain leg arteries. It helps researchers understand which treatments work best and what outcomes to expect.
This trial tests a new biological graft to replace or bypass damaged arteries in the legs or abdomen. It may be an option if you need surgery to improve blood flow and don't have a healthy vein available for the repair.
This study is collecting information from patients who have already had surgery to repair or replace blood vessels using Intervascular grafts or patches. Researchers will look at past medical records to see how well these devices work over time.
This study follows people with kidney failure who need dialysis access, when they receive an AV (artery-to-vein) access graft made from a processed donor artery. It’s meant to track safety and how well the new graft performs in real-world care.
Hear when a new Peripheral Arterial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.